Your session is about to expire
← Back to Search
Investigational Chickenpox Vaccine for Chickenpox
Study Summary
This trial assesses the safety and efficacy of an investigational chickenpox vaccine in young children.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2014 Phase 3 trial • 720 Patients • NCT01411241Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had chickenpox in the past.My newborn was born before 28 weeks of pregnancy.You have a weakened immune system.I am between 12 and 15 months old.I received the pneumococcal vaccine as a baby, following my country's guidelines.I haven't received immunoglobulins or blood products in the last 6 months.I have been vaccinated against measles, mumps, rubella, hepatitis A, and/or chickenpox.My guardian can meet the study's requirements like filling out diaries and attending visits.You can't take any experimental or unregistered medications, vaccines or medical devices 30 days before or during the study period.I haven't taken long-term immune system drugs or high-dose steroids recently.I received the pneumococcal vaccine series as a baby, following my country's guidelines.You were born with significant physical abnormalities or defects, as determined by the study doctor.I haven't received vaccines not allowed by the study within 30 days before or 43 days after my treatment, except for the flu shot.My guardian has given written consent for me to participate.You are in good health based on your medical history and physical examination.I am not taking long-acting immune-modifying drugs during the study.I do not have uncontrolled seizures or neurological disorders.You are allergic to latex.The doctor thinks that participating in the study could be risky for you because of other health issues you have.The parent or legal guardian of the participant has signed a form giving permission for them to take part in the study.I still have symptoms from a past COVID-19 infection.I have received a booster dose of a pneumococcal vaccine.My guardian can meet the study's requirements like filling out diaries and attending visits.I can receive any vaccine appropriate for my age after Visit 3.I am between 12 and 15 months old.
- Group 1: VNS_High Group
- Group 2: VV_Lot1 and Lot2 Pooled Group
- Group 3: VNS_Low Group
- Group 4: VNS_Med Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this experiment only include people over 40 in the control group?
"The age range for patients that this study can accept is 12-15 months old."
What does the Measles, mumps, and rubella vaccine help protect patients from?
"The measles, mumps, and rubella vaccine is not only used to treat mumps, but also other conditions like herpes zoster, typhoid fever, and rubella."
Could I possibly join this experiment?
"The requirements for this study are that potential participants must have had chickenpox and be between 12 and 15 months old. This particular trial is looking for approximately 800 patients in total."
Are there any unfilled positions for participants in this research?
"That is correct. The clinical trial is currently ongoing and recruiting patients at 39 different sites. So far, they have admitted 800 people into the study."
Is it safe for patients to receive the Measles, mumps, and rubella vaccine?
"The Measles, mumps, and rubella vaccine is currently in Phase 2 of clinical trials. While there is some data supporting its safety, more research needs to be done to confirm its efficacy."
Could you please name a few more examples of research surrounding the MMR vaccine?
"23 different clinical trials are currently underway to study the Measles, mumps, and rubella vaccine. Of these ongoing trials, 7 have reached Phase 3. Although many of the Houston-based studies are for Measles, mumps, and rubella vaccines specifically, 593 locations around the world are running similar investigations."
How many hospitals are conducting this research project?
"Currently, there are a total of 39 clinical trial sites. These include locations in Erie, Shreveport, Barnwell and 36 other places. If you choose to participate in this trial, it would be convenient for you to select the nearest clinic to cut down on travel time."
How many people can join this experiment at most?
"That is correct. As of 7/15/2022, this study was still recruiting patients which is evident from the information provided on clinicaltrials.gov. This trial was created on 2/3/2022 and was looking for 800 individuals to participate across 39 different sites."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger